Evaluation of Plenum® Tissue Ortho to Prevent Epidural Fibrosis and Post-laminectomy Syndrome.
NCT ID: NCT05776628
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
36 participants
INTERVENTIONAL
2024-04-30
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Diskectomy SpineJet x Open Microdiskectomy in Treatment of Lumbar Radiculopathy
NCT01367860
Regenexx™ PL-Disc Versus Steroid Epidurals for Lumbar Radiculopathy
NCT01850771
Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease
NCT03827096
Restore CLINICAL TRIAL
NCT01609374
A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain
NCT00220935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The groups will be compared regarding improving patients' quality of life, evaluation of epidural fibrosis, and device safety.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polydioxanone membrane
After flavectomy and manipulation of the spinal nerve and dura mater to resect the herniated intervertebral disk, the membrane will be placed on top of the dura mater.
Plenum® Tissue ortho membrane (polydioxanone membrane)
Membrane addition after flavectomy and spinal nerve and dura mater manipulation.
Control
The microdiscectomy procedure will be performed routinely, without the addition of any device over the dura mater.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plenum® Tissue ortho membrane (polydioxanone membrane)
Membrane addition after flavectomy and spinal nerve and dura mater manipulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have already undergone conservative treatment (treatment with medication and physiotherapy) for at least 6 weeks, but have not shown improvement;
* Non-pregnant women or women of childbearing age who use contraceptive methods;
* Having signed the free and informed consent form (TCLE).
Exclusion Criteria
* Cauda equina syndrome;
* Strength deficit characterized by strength equal to or less than III/V;
* Previous surgery of the lumbar spine;
* Patientes who have wound healing disorders;
* Patients with contraindications for evaluating MRI with the use of contrast;
* More than 1 herniated disk.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Irmandade da Santa Casa de Misericordia de Sao Paulo
OTHER
M3 Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sybele Saska Specian, PhD
Role: STUDY_DIRECTOR
M3 Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M3 Health
Jundiaí, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1302-0033
Identifier Type: REGISTRY
Identifier Source: secondary_id
Regenerative membrane
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.